Molecular Classification of Unknown Primary Cancer

Seminars in Oncology

Volumn 36, Issue 1, 2009, Pages 38-43

  Bender, Richard A ^a   Erlander, Mark G ^b  

^a Agendia Inc   (United States)

^b BioTheranostics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER OF UNKNOWN PRIMARY SITE; DNA MICROARRAY; GENE EXPRESSION; GENOMICS; HUMAN; MICROARRAY ANALYSIS; PATHOLOGIST; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT PLANNING;

GENE EXPRESSION PROFILING; HUMANS; NEOPLASMS, UNKNOWN PRIMARY;

EID: 58549117539     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2008.10.002     Document Type: Article

References (26)

1. Pentheroudakis G., Briasoulis E., and Pavlidis N. Cancer of unknown primary site: missing primary or missing biology?. Oncologist 12 (2007) 418-425
2. Varadhachary G.R. Carcinoma of unknown primary. Gastrointest Cancer Res 1 (2007) 229-235
3. Fodor S.P., Rava R.P., Huang X.C., et al., Pease A.C., Holmes C.P., Adams C.L. Multiplexed biochemical arrays with biological chips. Nature 364 (1993) 555-556
4. Schena M., Shalon D., Davis R.W., and Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270 (1995) 467-470
5. Sotiriou C., and Piccart M.J. Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?. Nature Rev Cancer 7 (2007) 545-553
6. Schulze A., and Downward J. Navigating gene expression using microarrays-a technology review. Nature Cell Biol 3 (2001) E190-E195
7. Gibson U.E., Heid C.A., and Williams P.M. A novel method for real time quantitative RT-PCR. Genome Res 6 (1996) 995-1001
8. Skrzypski M. Quantitative reverse transcriptase real-time polymerase chain reaction (qRT-PCR) in translational oncology: lung cancer perspective. Lung Cancer 59 (2008) 147-154
9. Applied Biosystems Tutorial. Real-time PCR vs. traditional PCR. http://www.appliedbiosystems.com/support/tutorials/pdf/rtpcr_vs_tradpcr.pdf. Accessed Nov 4, 2008.
10. Ma X.-J., Patel R., Wang X., Salunga R., Murage J., Rupal D., et al. Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction array. Arch Pathol Lab Med 130 (2006) 465-473
11. Bridgewater J., van Laar R., Floore A., and Van't Veer L. Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary. Br J Cancer 98 (2008) 1425-1430
12. Golub T.R., Slonim D.K., Tamayo P., Huard C., Gaasenbeek M., Mesirov J.P., et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286 (1999) 531-537
13. Ramaswamy S., Tamayo P., Rifkin R., Mukherjee S., Yeang C.-H., Angelo H., et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A 98 (2001) 15149-15154
14. Su A.I., Welsh J.B., Sapinoso L.M., Kern S.G., Dimitrov P., Lapp H., et al. Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 61 (2001) 7388-7393
15. Bloom G., Yang I.V., Boulware D., Kwong K.Y., Coppola D., Eschrich S., et al. Multi-platform, multi-site, microarray-based human tumor classification. Am J Pathol 164 (2004) 9-16
16. Tothill R.W., Kowalczyk A., Rischin D., Bousioutas A., Haviv I., van Laar R.K., et al. An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin. Cancer Res 65 (2005) 4031-4040
17. Talantov D., Baden J., and Jatkoe T. A quantitative reverse transcriptase-polymerase chain reaction array to identify metastatic carcinoma tissue of origin. J Mol Diagn 8 (2006) 320-329
18. Rosenfeld N., Aharonov R., Meiri1 E., Rosenwald S., Spector Y., Zepeniuk M., et al. MicroRNAs accurately identify cancer tissue origin. Nature Biotech 26 (2008) 462-469
19. Medieros F, Kolbert CP, Rohakhtar FR, Lindgren TK, Wilson MJ, Rigl CY, et al. Gene expression microarray-based test may identify primary tumor site in patients with carcinoma of unknown primary (CUP) [abstract]. Association for Molecular Pathology Annual Meeting, Grapevine, TX, Oct 29-Nov 2, 2008.
20. Horlings H.M., van Laar R., Kerst J.-M., Helgason H.H., Wesseling J., van der Hoeven J.J., et al. Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary. J Clin Oncol 26 (2008) 4435-4441
21. Pavlidis N., and Fizazi K. Cancer of unknown primary (UPC). Crit Rev Oncol Hematol 54 (2005) 243-250
22. Pentheroudakis G., Golfinopulos V., and Pavlidis N. Switching benchmarks in cancer of unknown primary: from autopsy to microarray. Eur J Cancer 43 (2007) 2026-2036
23. Hainsworth J.D., Lennington W.J., and Greco F.A. Overexpression of Her-2 in patients with poorly differentiated carcinoma or poorly differentiated adenocarcinoma of unknown primary site. J Clin Oncol 18 (2000) 632-635
24. Petty R.D., Nicolson M.C., Kerr K.M., Collie-Duguid E., and Murray G.I. Gene expression profiling in non-small cell lung cancer: from molecular mechanisms to clinical application. Clin Cancer Res 10 (2004) 3237-3248
25. Varadhachary G., Talantov D., Raber M., Meng C., Hess K.R., Jatkoe T., et al. Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation. J Clin Oncol 26 (2008) 4442-4448
26. Ismael G., de Azambuja E., and Awanda A. Molecular profiling of a tumor of unknown origin [letter]. N Engl J Med 355 (2006) 1071-1072